Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion

AIM: To evaluate the association between the size of peripheral retinal non-perfusion and the number of intravitreal ranibizumab injections in patients with treatment-naive branch retinal vein occlusion (BRVO) and macular edema. METHODS: A total of 53 patients with treatment-naive BRVO and macular...

Full description

Bibliographic Details
Main Authors: Kaveh Abri Aghdam, Lukas Reznicek, Mostafa Soltan Sanjari, Carsten Framme, Anna Bajor, Annemarie Klingenstein, Marcus Kernt, Florian Seidensticker
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2016-06-01
Series:International Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.cn/en_publish/2016/6/20160612.pdf
_version_ 1818822913556480000
author Kaveh Abri Aghdam
Lukas Reznicek
Mostafa Soltan Sanjari
Carsten Framme
Anna Bajor
Annemarie Klingenstein
Marcus Kernt
Florian Seidensticker
author_facet Kaveh Abri Aghdam
Lukas Reznicek
Mostafa Soltan Sanjari
Carsten Framme
Anna Bajor
Annemarie Klingenstein
Marcus Kernt
Florian Seidensticker
author_sort Kaveh Abri Aghdam
collection DOAJ
description AIM: To evaluate the association between the size of peripheral retinal non-perfusion and the number of intravitreal ranibizumab injections in patients with treatment-naive branch retinal vein occlusion (BRVO) and macular edema. METHODS: A total of 53 patients with treatment-naive BRVO and macular edema were included. Each patient underwent a full ophthalmologic examination including optical coherence tomography (OCT) imaging and ultra wide-field fluorescein angiography (UWFA). Monthly intravitreal ranibizumab injections were applied according to the recommendations of the German Ophthalmological Society. Two independent, masked graders quantified the areas of peripheral retinal non-perfusion. RESULTS: Intravitreal injections improved best-corrected visual acuity (BCVA) significantly from 22.23±16.33 Early Treatment of Diabetic Retinopathy Study (ETDRS) letters to 36.23±15.19 letters (P<0.001), and mean central subfield thickness significantly reduced from 387±115 µm to 321±115 µm (P=0.01). Mean number of intravitreal ranibizumab injections was 3.61±1.56. The size of retinal non-perfusion correlated significantly with the number of intravitreal ranibizumab injections (R=0.724, P<0.001). CONCLUSION: Peripheral retinal non-perfusion in patients with BRVO associates significantly with intravitreal ranibizumab injections in patients with BRVO and macular edema.
first_indexed 2024-12-18T23:31:38Z
format Article
id doaj.art-33c47f64f9cd400dbea0a87eaccae8fb
institution Directory Open Access Journal
issn 2222-3959
2227-4898
language English
last_indexed 2024-12-18T23:31:38Z
publishDate 2016-06-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series International Journal of Ophthalmology
spelling doaj.art-33c47f64f9cd400dbea0a87eaccae8fb2022-12-21T20:47:40ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982016-06-019685886210.18240/ijo.2016.06.12Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusionKaveh Abri Aghdam0Lukas Reznicek1Mostafa Soltan Sanjari2Carsten Framme3Anna Bajor4Annemarie Klingenstein5Marcus Kernt6Florian Seidensticker7Department of Ophthalmology, University Eye Hospital, Medical School of Hannover, Carl-Neuberg-Straße 1, Hannover 30625, GermanyDepartment of Ophthalmology, Ludwig Maximilians University, Mathildenstr. 8, Munich 80336, GermanyEye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Sattarkhan-Niayesh Street, Tehran 14456-13131, IranDepartment of Ophthalmology, University Eye Hospital, Medical School of Hannover, Carl-Neuberg-Straße 1, Hannover 30625, GermanyDepartment of Ophthalmology, University Eye Hospital, Medical School of Hannover, Carl-Neuberg-Straße 1, Hannover 30625, GermanyDepartment of Ophthalmology, Ludwig Maximilians University, Mathildenstr. 8, Munich 80336, GermanyDepartment of Ophthalmology, Ludwig Maximilians University, Mathildenstr. 8, Munich 80336, GermanyDepartment of Ophthalmology, University Eye Hospital, Medical School of Hannover, Carl-Neuberg-Straße 1, Hannover 30625, Germany; Department of Ophthalmology, Ludwig Maximilians University, Mathildenstr. 8, Munich 80336, GermanyAIM: To evaluate the association between the size of peripheral retinal non-perfusion and the number of intravitreal ranibizumab injections in patients with treatment-naive branch retinal vein occlusion (BRVO) and macular edema. METHODS: A total of 53 patients with treatment-naive BRVO and macular edema were included. Each patient underwent a full ophthalmologic examination including optical coherence tomography (OCT) imaging and ultra wide-field fluorescein angiography (UWFA). Monthly intravitreal ranibizumab injections were applied according to the recommendations of the German Ophthalmological Society. Two independent, masked graders quantified the areas of peripheral retinal non-perfusion. RESULTS: Intravitreal injections improved best-corrected visual acuity (BCVA) significantly from 22.23±16.33 Early Treatment of Diabetic Retinopathy Study (ETDRS) letters to 36.23±15.19 letters (P<0.001), and mean central subfield thickness significantly reduced from 387±115 µm to 321±115 µm (P=0.01). Mean number of intravitreal ranibizumab injections was 3.61±1.56. The size of retinal non-perfusion correlated significantly with the number of intravitreal ranibizumab injections (R=0.724, P<0.001). CONCLUSION: Peripheral retinal non-perfusion in patients with BRVO associates significantly with intravitreal ranibizumab injections in patients with BRVO and macular edema.http://www.ijo.cn/en_publish/2016/6/20160612.pdfangiographybranch retinal vein occlusionnon-perfusionretinawide-fieldwide-field
spellingShingle Kaveh Abri Aghdam
Lukas Reznicek
Mostafa Soltan Sanjari
Carsten Framme
Anna Bajor
Annemarie Klingenstein
Marcus Kernt
Florian Seidensticker
Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion
International Journal of Ophthalmology
angiography
branch retinal vein occlusion
non-perfusion
retina
wide-field
wide-field
title Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion
title_full Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion
title_fullStr Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion
title_full_unstemmed Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion
title_short Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion
title_sort peripheral retinal non perfusion and treatment response in branch retinal vein occlusion
topic angiography
branch retinal vein occlusion
non-perfusion
retina
wide-field
wide-field
url http://www.ijo.cn/en_publish/2016/6/20160612.pdf
work_keys_str_mv AT kavehabriaghdam peripheralretinalnonperfusionandtreatmentresponseinbranchretinalveinocclusion
AT lukasreznicek peripheralretinalnonperfusionandtreatmentresponseinbranchretinalveinocclusion
AT mostafasoltansanjari peripheralretinalnonperfusionandtreatmentresponseinbranchretinalveinocclusion
AT carstenframme peripheralretinalnonperfusionandtreatmentresponseinbranchretinalveinocclusion
AT annabajor peripheralretinalnonperfusionandtreatmentresponseinbranchretinalveinocclusion
AT annemarieklingenstein peripheralretinalnonperfusionandtreatmentresponseinbranchretinalveinocclusion
AT marcuskernt peripheralretinalnonperfusionandtreatmentresponseinbranchretinalveinocclusion
AT florianseidensticker peripheralretinalnonperfusionandtreatmentresponseinbranchretinalveinocclusion